Supplementary protection
LT - Anti-CD38 plius kortikosteroidai, plius nekortikosteroidinis chemoterapinis agentas, skirti vėžio gydymui
EN - ANTI-CD38 PLUS CORTICOSTEROIDS PLUS A NON-CORTICOSTEROID CHEMOTHERAPEUTIC FOR TREATING TUMORS
SPC
| (11) |
Number of the document |
|
| (68) |
Number of the document |
2081595
|
| (21) |
Application number for Supplementary Protection Certificate |
PA 2019 516 |
| (22) |
Date of filing the application |
2019-10-04 |
| (41) |
Date of publication of the application |
2019-10-25 |
|
Date of publication of SPC |
|
| (24) |
Date of coming into effect of SPC |
|
Applicant
| (71) |
Genmab A/S,
Carl Jacobsens Vej 30, 2500 Valby,
DK
|
Grantee
| (73) |
Genmab A/S,
Carl Jacobsens Vej 30, 2500 Valby,
DK
|
Attorney or representative
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
Number, date and code of the country of origin of the first authorization to place the medicinal or plant protection product on the market within regional economic community
| (93) |
EU/1/16/1101/001-002, 2016-05-20
|
Name of the product protected by the basic patent
| (95) |
Daratumumabas, bortezomibas, melfalanas ir prednizonas |
Legal status
|
SPC application published
|
|
